C-Rad AB


Pressmeddelande   •   Apr 27, 2009 10:22 CEST

C-RAD AB with its three fully owned subsidiaries is all active in the field of radiation therapy. According to plan has now the Sentinel laser scanner been certified for use in Japan and introduction to Japanese market was done at the annual ITEM meeting in Yokohama, Japan, recently. The first ordered Sentinel system has now also been delivered to Japan.

The Japanese radiotherapy market is highly interesting with large number of clinics and a high degree of advanced radiation procedures. In accordance with the strategy of C-RAD to establish a firm presence in selected important markets, Japan has been a prioritized country. The required certification approval to sell and use the Sentinel laser scanner system in Japan was received earlier this year. Following this certification approval C-RAD attended the annual ITEM congress in Yokohama, April 17 - 19.

The ITEM congress is one of the most important events in Japan and attracts interest and participation from the radiotherapy society of Japan. C-RAD exhibited together with our distributor for Japan, Advanced Radiation Devices, the unique laser scanner system Sentinel. The Sentinel offers improved accuracy in combination with increased efficiency in radiation treatments and the exhibition with demonstrations of the products capability attracted lots of interest from the participants.

With the certification approval in place and the launch of the product at ITEM an important milestone for C-RAD has been taken. These events are now followed by intensive marketing and sale activities in Japan.

Erik Hedlund, CEO, C-RAD AB:
- We are excited about the response Sentinel received from the Japanese radiotherapy society. The unique features of Sentinel received good response from the highly skilled and advanced customers of Japan. As Japan is one of the major markets worldwide we are pleased to have the certification for sale of the product in place and can now also offer this to customers in Japan.


For further information:
Erik Hedlund, CEO C-RAD AB
Telefon: 018- 66 69 31
E-post: erik.hedlund@c-rad.se

The following documents can be retrieved from beQuoted
C-RAD Pressrelease 2009-04-27 (English).pdf

Mer information från beQuoted
Nyhetssida C-RAD

About C-RAD
AB C-RAD develops new and innovative solutions for the use in advanced radiation therapy. The company group of C-RAD offers products and solutions for patient positioning, tumor localization and radiation treatment systems. End users are radiation therapy clinics worldwide. All product development is conducted in three fully owned subsidiaries; C-RAD Positioning AB, C-RAD Imaging AB and C-RAD Innovation AB. C-RAD Imaging AB is located in Östersund while the other companies are located in Uppsala. Number of employees are currently 19 people. The activities in C-RAD AB originates in research and development at the Karolinska Institutet in Solna and the The Royal Institute of Technology in Stockholm. Sales of the company's first product, the C-RAD SentinelTM, started during autumn 2006. A co-operation agreement has been signed with the German company LAP. Distribution agreements has also been established for USA, Japan, Korea, China and Italy. C-RAD AB is a listed company on Aktietorget since 23 July 2007.